Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
Abroad (travel likely)Recruiting
Conditions
Alzheimer s Disease · MCI Conversion to Dementia · pTau217 · Biomarkers
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Insigth Hospital and Medical Center Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Elisabeth Thijssen, PhD) · elisabeth@neurogenbiomarking.com · +16282788161Insight Hospital and Medical Center Dearborn, Dearborn, Michigan, United States
Insight Institute of Neurology and Neurosurgery, Flint, Michigan, United States
Memorial Healthcare Hospital, Owosso, Michigan, United States
Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States
Study leads
Rany Aburashed
Principal Investigator
Insight Health Systems